Inmed Pharmaceuticals Inc. · NASDAQ:INM
ADAR1 Capital Management, LLC bought 9,569 Inmed Pharmaceuticals Inc. shares (Form 4)
Traded Oct 13 to Oct 15, 2026 · Filed Oct 15, 2026
From Oct 13 to Oct 15, 2026, ADAR1 Capital Management, LLC (10% owner) bought 9,569 Inmed Pharmaceuticals Inc. shares at an average US$1.33 for US$12,719, leaving 955,493 shares. Filed Oct 15, 2026 (Form 4).
- Bought
- 9,569 shares
- Price
- US$1.33 average (US$1.32 to US$1.33)
- Value
- US$12,719
- Holding after
- 955,493 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Shares | Buy | 564 | US$1.33 | 946,488 | Indirect |
| Oct 14, 2026 | Common Shares | Buy | 8,021 | US$1.33 | 954,509 | Indirect |
| Oct 15, 2026 | Common Shares | Buy | 984 | US$1.32 | 955,493 | Indirect |
Source
Download original · View original at SEC
Related
- Inmed Pharmaceuticals Inc.
- ADAR1 Capital Management, LLC
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 20, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026
- Form 4 · ADAR1 Capital Management, LLC · Jul 17, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · Schneeberger Daniel · Sep 16, 2026
- Schedule 13G · Ikarian Capital, LLC · Aug 14, 2026
- Form 4 · Vivo Opportunity Cayman Fund, L.P. · Jul 16, 2026
- Form 4 · Vivo Opportunity, LLC · Jul 2, 2026